SCHEMBL9755328

SCHEMBL9755328

Cc1ccc2cc3ccc(C)cc3nc2c1

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 4/20 0.65
NQO2 P16083 1/20 0.58
CYP2A6 P11509 3/20 0.55
ALDH1A1 P00352 8/20 0.53
KMT2A Q03164 2/20 0.53
NPSR1 Q6W5P4 1/20 0.53
TERT O14746 2/20 0.52
APP P05067 1/20 0.52
NCK1 P16333 1/20 0.52
BACE1 P56817 1/20 0.52
LMNA P02545 2/20 0.50
ACHE P22303 2/20 0.50
MEN1 O00255 1/20 0.50
F2 P00734 1/20 0.50
CHRM2 P08172 1/20 0.50
HTR1A P08908 1/20 0.50
ADRA2A P08913 1/20 0.50
ADORA3 P0DMS8 1/20 0.50
MAOA P21397 1/20 0.50
DRD1 P21728 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29660577 1.00 CYP1A2 (0.65) CYP1A2NQO2CYP2A6ALDH1A1KMT2A
SCHEMBL9755319 0.91 CYP1A2 (0.65) CYP1A2NQO2CYP2A6ALDH1A1KMT2A
SCHEMBL862528 0.89 CYP1A2 (0.54) CYP1A2NQO2CYP2A6ALDH1A1KMT2A
SCHEMBL6681790 0.89 NQO2 (0.65) CYP1A2NQO2CYP2A6ALDH1A1KMT2A
Acetic Acid SCHEMBL28499052 0.87 ALDH1A1 (0.62) CYP1A2NQO2CYP2A6ALDH1A1KMT2A
Hydrochloric Acid SCHEMBL29033530 0.87 NQO2 (0.63) CYP1A2NQO2CYP2A6ALDH1A1KMT2A
Iodide SCHEMBL27917416 0.87 NQO2 (0.63) CYP1A2NQO2CYP2A6ALDH1A1KMT2A
Iodide SCHEMBL1353852 0.87 NQO2 (0.63) CYP1A2NQO2CYP2A6ALDH1A1KMT2A
SCHEMBL12620669 0.87 LMNA (0.75) CYP1A2NQO2ALDH1A1KMT2ANPSR1
SCHEMBL20008616 0.85 TERT (0.80) CYP1A2NQO2CYP2A6ALDH1A1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 73 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12043749-B2 Method for producing ink composition SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2024-07-23 US disclosed
US-12043749-B2 Method for producing ink composition SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2024-07-23 US disclosed
US-11917839-B2 High signal-to-noise ratio photoelectric conversion element SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2024-02-27 US disclosed
US-11917839-B2 High signal-to-noise ratio photoelectric conversion element SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2024-02-27 US disclosed
US-20240023422-A1 COMPOSITION, FILM, ORGANIC PHOTOELECTRIC CONVERSION ELEMENT, AND PHOTODETECTION ELEMENT SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2024-01-18 US disclosed
US-20240023422-A1 COMPOSITION, FILM, ORGANIC PHOTOELECTRIC CONVERSION ELEMENT, AND PHOTODETECTION ELEMENT SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2024-01-18 US disclosed
US-11877459-B2 Light detecting element SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2024-01-16 US disclosed
US-11877459-B2 Light detecting element SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2024-01-16 US disclosed
WO-2023238764-A1 COMPOSITION, FILM, ORGANIC PHOTOELECTRIC CONVERSION ELEMENT, AND PHOTODETECTION ELEMENT 住友化学株式会社 2023-12-14 WO disclosed
US-20230363184-A1 PHOTOELECTRIC CONVERSION ELEMENT AND METHOD FOR MANUFACTURING SAME SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2023-11-09 US disclosed
US-20120211082-A1 PHOTOELECTRIC CONVERSION DEVICE AND SOLAR CELL USING THE SAME MITSUBISHI CHEMICAL CORPORATION (JP) 2012-08-23 US disclosed
US-20120211082-A1 PHOTOELECTRIC CONVERSION DEVICE AND SOLAR CELL USING THE SAME MITSUBISHI CHEMICAL CORPORATION (JP) 2012-08-23 US disclosed
US-20120040380-A1 OPTICALLY-DETECTABLE ENZYME SUBSTRATES AND THEIR METHOD OF USE Life Technologies Corporation (US) 2012-02-16 US disclosed
US-20110004102-A1 ORGANIC PIEZOELECTRIC MATERIAL, ULTRASONIC OSCILLATOR USING THE SAME, METHOD FOR PRODUCING THE ULTRASONIC OSCILLATOR, ULTRASONIC PROBE AND ULTRASONIC MEDICAL DIAGNOSTIC IMAGING DEVICE KONICA MINOLTA MEDICAL & GRAPHIC, INC. (JP) 2011-01-06 US disclosed
US-20090047692-A1 OPTICALLY-DETECTABLE ENZYME SUBSTRATES AND THEIR METHOD OF USE INVITROGEN CORPORATION (US) 2009-02-19 US disclosed
US-20070197699-A1 Novel substituted-polyaryl chromophoric compounds TRANSPHOTONICS, LLC (US) 2007-08-23 US disclosed
US-20070197699-A1 Novel substituted-polyaryl chromophoric compounds TRANSPHOTONICS, LLC (US) 2007-08-23 US disclosed
US-7205347-B2 Substituted-polyaryl chromophoric compounds TRANS PHOTONICS, LLC. (US) 2007-04-17 US disclosed
US-7205347-B2 Substituted-polyaryl chromophoric compounds TRANS PHOTONICS, LLC. (US) 2007-04-17 US disclosed
WO-1991005770-A1 POTENTIAL ANTICANCER AGENTS DERIVED FROM ACRIDINE SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH (US) 1991-05-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090047692-A1 OPTICALLY-DETECTABLE ENZYME SUBSTRATES AND THEIR METHOD OF USE MGAM, LCT, GAA CYP1A2 1699/4885NQO2 307/4885CYP2A6 1132/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.